This phase II trial tests how well the combination of celecoxib with durvalaumab and tremellimumab works in treating patients with hepatocellular cancer (liver…

Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more

~Estimated

~$10 – $6,250

Emory UniversityNCT07174570

Phase 1

Phase I Study of GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

Background: A new cancer treatment takes a person s own T cells, modifies them in a laboratory so they can better fight cancer cells, and then gives them back…

Hepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05003895

← PreviousPage 2 of 2Next →